FBXO34 promotes latent HIV-1 activation by post-transcriptional modulation

References

• Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384(9939):258–271.
   PubMed Web of Science ®Google Scholar
• Bailey H, Zash R, Rasi V, et al. HIV treatment in pregnancy. Lancet HIV. 2018;5(8):e457–e467.
   PubMed Web of Science ®Google Scholar
• Kanters S, Vitoria M, Doherty M, et al. Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis. Lancet HIV. 2016;3(11):e510–e520.
   PubMed Web of Science ®Google Scholar
• Ruelas DS, Greene WC. An integrated overview of HIV-1 latency. Cell. 2013;155(3):519–529.
   PubMed Web of Science ®Google Scholar
• Chun TW, Engel D, Berrey MM, et al. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A. 1998;95(15):8869–8873.
   PubMed Web of Science ®Google Scholar
• Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997;278(5341):1295–1300.
   PubMed Web of Science ®Google Scholar
• Siliciano JD, Kajdas J, Finzi D, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med. 2003;9(6):727–728.
   PubMed Web of Science ®Google Scholar
• Cohn LB, Chomont N, Deeks SG. The biology of the HIV-1 latent reservoir and implications for cure strategies. Cell Host Microbe. 2020;27(4):519–530.
   PubMed Web of Science ®Google Scholar
• Katlama C, Deeks SG, Autran B, et al. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet. 2013;381(9883):2109–2117.
   PubMed Web of Science ®Google Scholar
• Siliciano JD, Siliciano RF. Recent developments in the effort to cure HIV infection: going beyond N = 1. J Clin Invest. 2016;126(2):409–414.
   PubMed Web of Science ®Google Scholar
• Sengupta S, Siliciano RF. Targeting the latent reservoir for HIV-1. Immunity. 2018;48(5):872–895.
   PubMed Web of Science ®Google Scholar
• Cary DC, Fujinaga K, Peterlin BM. Molecular mechanisms of HIV latency. J Clin Invest. 2016;126(2):448–454.
   PubMed Web of Science ®Google Scholar
• Verdin E, Paras P, Van Lint C. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 1998;12(8):3249–3259.
   Google Scholar
• Bieniasz PD, Grdina TA, Bogerd HP, et al. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc Natl Acad Sci U S A. 1998;96(14):7791–7796.
   Web of Science ®Google Scholar
• Blazkova J, Trejbalova K, Gondois-Rey F, et al. Cpg methylation controls reactivation of HIV from latency. PLoS Pathog. 2009;5(8):e1000554.
   PubMed Web of Science ®Google Scholar
• Archin NM, Sung JM, Garrido C, et al. Eradicating HIV-1 infection: seeking to clear a persistent pathogen. Nat Rev Microbiol. 2014;12(11):750–764.
   PubMed Web of Science ®Google Scholar
• Nguyen K, Das B, Dobrowolski C, et al. Multiple histone lysine methyltransferases are required for the establishment and maintenance of HIV-1 latency. mBio. 2017;8(1):e00133–17.
   PubMed Web of Science ®Google Scholar
• Qu D, Sun WW, Li L, et al. Long noncoding RNA MALAT1 releases epigenetic silencing of HIV-1 replication by displacing the polycomb repressive complex 2 from binding to the LTR promoter. Nucleic Acids Res. 2019;47(6):3013–3027.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhao X, Zhu Y, et al. FKBP3 induces human immunodeficiency virus type 1 latency by recruiting histone deacetylase 1/2 to the viral long terminal repeat. mBio. 2021;12(4):e0079521.
   PubMed Web of Science ®Google Scholar
• Le Douce V, Colin L, Redel L, et al. LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing. Nucleic Acids Res. 2012;40(5):1904–1915.
   PubMed Web of Science ®Google Scholar
• Lusic M, Marcello A, Cereseto A, et al. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J. 2003;22(24):6550–6561.
   PubMed Web of Science ®Google Scholar
• Ding D, Qu X, Li L, et al. Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation. Virology. 2013;440(2):182–189.
   PubMed Web of Science ®Google Scholar
• Chéné ID, Basyuk E, Lih Y I, et al. Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency. EMBO J. 2007;26(2):424–435.
   PubMed Web of Science ®Google Scholar
• Acchioni C, Remoli AL, Marsili G, et al. Alternate NF-κB-independent signaling reactivation of latent HIV-1 provirus. J Virol. 2019;93(18):e00495–19.
   PubMed Web of Science ®Google Scholar
• Chaudhary P, Khan SZ, Rawat P, et al. HSP70 binding protein 1 (HspBP1) suppresses HIV-1 replication by inhibiting NF-κB mediated activation of viral gene expression. Nucleic Acids Res. 2016;44(4):1613–1629.
   PubMed Web of Science ®Google Scholar
• Couturier J, Orozco AF, Liu H, et al. Regulation of cyclin T1 during HIV replication and latency establishment in human memory CD4 T cells. Virol J. 2019;16(1):22.
   PubMedGoogle Scholar
• Bieniasz PD, Grdina TA, Bogerd HP, et al. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 1998;17(23):7056–7065.
   PubMed Web of Science ®Google Scholar
• Rice AP. The HIV-1 Tat protein: mechanism of action and target for HIV-1 cure strategies. Curr Pharm Des. 2017;23(28):4098–4102.
   PubMed Web of Science ®Google Scholar
• Lu H, Li Z, Zhang W, et al. Gene target specificity of the Super Elongation Complex (SEC) family: how HIV-1 Tat employs selected SEC members to activate viral transcription. Nucleic Acids Res. 2015;43(12):5868–5879.
   PubMed Web of Science ®Google Scholar
• Kula A, Marcello A. Dynamic post-transcriptional regulation of HIV-1 gene expression. Biology (Basel). 2012;1(2):116–133.
   PubMedGoogle Scholar
• Kennedy EM, Bogerd HP, Kornepati AVR, et al. Posttranscriptional m6A editing of HIV-1 mRNAs enhances viral gene expression. Cell Host Microbe. 2016;19(5):675–685.
   PubMed Web of Science ®Google Scholar
• Wang P, Qu X, Zhou X, et al. Two cellular microRNAs, miR-196b and miR-1290, contribute to HIV-1 latency. Virology. 2015;486:228–238.
   PubMed Web of Science ®Google Scholar
• Kim Y, Anderson JL, Lewin SR. Getting the “kill” into “shock and kill”: strategies to eliminate latent HIV. Cell Host Microbe. 2018;23(1):14–26.
   PubMed Web of Science ®Google Scholar
• Ait-Ammar A, Kula A, Darcis G, et al. Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs. Front Microbiol. 2020;10:3060.
   PubMed Web of Science ®Google Scholar
• Bashiri K, Rezaei N, Nasi M, et al. The role of latency reversal agents in the cure of HIV: a review of current data. Immunol Lett. 2018;196:135–139.
   PubMed Web of Science ®Google Scholar
• Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819–823.
   PubMed Web of Science ®Google Scholar
• Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157(6):1262–1278.
   PubMed Web of Science ®Google Scholar
• Wang T, Wei JJ, Sabatini DM, et al. Genetic screens in human cells using the CRISPR-Cas9 system. Science. 2014;343(6166):80–84.
   PubMed Web of Science ®Google Scholar
• Shalem O, Sanjana NE, Hartenian E, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014;343(6166):84–87.
   PubMed Web of Science ®Google Scholar
• Zhang R, Miner JJ, Gorman MJ, et al. A CRISPR screen defines a signal peptide processing pathway required by flaviviruses. Nature. 2016;535(7610):164–168.
   PubMed Web of Science ®Google Scholar
• Li Y, Muffat J, Javed AO, et al. Genome-wide CRISPR screen for Zika virus resistance in human neural cells. Proc Natl Acad Sci U S A. 2019;116(19):9527–9532.
   PubMed Web of Science ®Google Scholar
• Park RJ, Wang T, Koundakjian D, et al. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat Genet. 2017;49(2):193–203.
   PubMed Web of Science ®Google Scholar
• Joung J, Konermann S, Gootenberg JS, et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat Protoc. 2017;12(4):828–863.
   PubMed Web of Science ®Google Scholar
• Yang X, Wang Y, Lu P, et al. PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK/NF-κB signaling. EMBO Rep. 2020;21(11):e49305.
   PubMed Web of Science ®Google Scholar
• Huang H, Kong W, Jean M, et al. A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG). Nucleic Acids Res. 2019;47(14):7333–7347.
   PubMed Web of Science ®Google Scholar
• Krasnopolsky S, Kuzmina A, Taube R. Genome-wide CRISPR knockout screen identifies ZNF304 as a silencer of HIV transcription that promotes viral latency. PLoS Pathog. 2020;16(9):e1008834.
   PubMed Web of Science ®Google Scholar
• Konermann S, Brigham MD, Trevino AE, et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2015;517(7536):583–588.
   PubMed Web of Science ®Google Scholar
• Qu X, Wang P, Ding D, et al. Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells. Nucleic Acids Res. 2013;41(16):7771–7782.
   PubMed Web of Science ®Google Scholar
• Krasnopolsky S, Marom L, Victor RA, et al. Fused in sarcoma silences HIV gene transcription and maintains viral latency through suppressing AFF4 gene activation. Retrovirology. 2019;16(1):16.
   PubMedGoogle Scholar
• Skowyra D, Craig KL, Tyers M, et al. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell. 1997;91(2):209–219.
   PubMed Web of Science ®Google Scholar
• Meng X, Liu X, Guo X, et al. FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells. Nature. 2018;564(7734):130–135.
   PubMed Web of Science ®Google Scholar
• Jin Y, Shenoy AK, Doernberg S, et al. FBXO11 promotes ubiquitination of the Snail family of transcription factors in cancer progression and epidermal development. Cancer Lett. 2015;362(1):70–82.
   PubMed Web of Science ®Google Scholar
• Bosque A, Planelles V. Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells. Methods. 2011;53(1):54–61.
   PubMed Web of Science ®Google Scholar
• Kim M, Hosmane NN, Bullen CK, et al. A primary CD4(+) T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence. Nat Protoc. 2014;9(12):2755–2770.
   PubMed Web of Science ®Google Scholar
• José DP, Bartholomeeusen K, Cunha RDD, et al. Reactivation of latent HIV-1 by new semi-synthetic ingenol esters. Virology. 2014;462-463:328–339.
   PubMed Web of Science ®Google Scholar
• Hotter D, Bosso M, Jønsson KL, et al. IFI16 targets the transcription factor Sp1 to suppress HIV-1 transcription and latency reactivation. Cell Host Microbe. 2019;25(6):858–872.
   PubMed Web of Science ®Google Scholar
• Liu Y, Fu Y, Wang Q, et al. Proteomic profiling of HIV-1 infection of human CD4+ T cells identifies PSGL-1 as an HIV restriction factor. Nat Microbiol. 2019;4(5):813–825.
   PubMed Web of Science ®Google Scholar
• Higuchi-Takeuchi M, Mori M, Matsui M. High-throughput analysis of rice genes by means of the heterologous full-length cDNA overexpressor (FOX)-hunting system. Int J Dev Biol. 2013;57(6-8):517–523.
   PubMed Web of Science ®Google Scholar
• Knudsen A, Vedeler CA. cDNA expression library screening for identification of novel onconeural antigens. Acta Neurol Scand Suppl. 2016;183:73–74.
   Google Scholar
• Mazari PM, Roth MJ. Library screening and receptor-directed targeting of gammaretroviral vectors. Future Microbiol. 2013;8(1):107–121.
   PubMed Web of Science ®Google Scholar
• Heaton BE, Kennedy EM, Dumm RE, et al. A CRISPR activation screen identifies a Pan-avian influenza virus inhibitory host factor. Cell Rep. 2017;20(7):1503–1512.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Sun F, Wang L, et al. Virus-induced p38 MAPK activation facilitates viral infection. Theranostics. 2020;10(26):12223–12240.
   PubMed Web of Science ®Google Scholar
• Rathore A, Iketani S, Wang P, et al. CRISPR-based gene knockout screens reveal deubiquitinases involved in HIV-1 latency in two Jurkat cell models. Sci Rep. 2020;10(1):5350.
   PubMed Web of Science ®Google Scholar
• Ali A, Raja R, Farooqui SR, et al. USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein. Biochem J. 2017;474(10):1653–1668.
   PubMed Web of Science ®Google Scholar
• Pan T, Song Z, Wu L, et al. USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication. Elife. 2019;8:e48318.
   PubMed Web of Science ®Google Scholar
• Liang T, Zhang Q, Wu Z, et al. UHRF1 suppresses HIV-1 transcription and promotes HIV-1 latency by competing with p-TEFb for ubiquitination-proteasomal degradation of Tat. mBio. 2021;12(4):e0162521.
   PubMed Web of Science ®Google Scholar
• Lund N, Milev MP, Wong R, et al. Differential effects of hnRNP D/AUF1 isoforms on HIV-1 gene expression. Nucleic Acids Res. 2012;40(8):3663–3675.
   PubMed Web of Science ®Google Scholar
• Scalabrin M, Frasson I, Ruggiero E, et al. The cellular protein hnRNP A2/B1 enhances HIV-1 transcription by unfolding LTR promoter G-quadruplexes. Sci Rep. 2017;7:45244.
   PubMed Web of Science ®Google Scholar
• Monette A, Ajamian L, López-Lastra M, et al. Human immunodeficiency virus type 1 (HIV-1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import: implications for HIV-1 gene expression. J Biol Chem. 2009;284(45):31350–31362.
   PubMed Web of Science ®Google Scholar
• Valente ST, Goff SP. Inhibition of HIV-1 gene expression by a fragment of hnRNP U. Mol Cell. 2006;23(4):597–605.
   PubMed Web of Science ®Google Scholar